CALC

CalciMedica (CALC)

About CalciMedica (CALC)

CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Details

Daily high
$5.34
Daily low
$4.52
Price at open
$4.52
52 Week High
$5.34
52 Week Low
$1.42
Market cap
66.7M
Dividend yield
0.00%
Volume
189,416
Avg. volume
129,518
P/E ratio
-2.88

CalciMedica News

Details

Daily high
$5.34
Daily low
$4.52
Price at open
$4.52
52 Week High
$5.34
52 Week Low
$1.42
Market cap
66.7M
Dividend yield
0.00%
Volume
189,416
Avg. volume
129,518
P/E ratio
-2.88